Similar articles

• Punch biopsy tissue: enzyme and receptor analyses as criteria for hormone responsiveness in the treatment of prostatic cancer--limitations.

  Bartsch G, Janetschek G, Daxenbichler G, Dietze O, Mikuz G. Bartsch G, et al. Prog Clin Biol Res. 1987;243A:101-10. Prog Clin Biol Res. 1987. PMID: 3658997 No abstract available.
• [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].

  Habib FK, Chisholm GD. Habib FK, et al. Arch Esp Urol. 1984 Dec;37 Suppl 2:751-9. Arch Esp Urol. 1984. PMID: 6085672 Spanish. No abstract available.
• A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.

  Barrack ER, Tindall DJ. Barrack ER, et al. Prog Clin Biol Res. 1987;239:155-87. Prog Clin Biol Res. 1987. PMID: 3309954 Review. No abstract available.
• [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].

  Fedotov IA, Denisov LE, Kozlov VP, Degtiar' VG. Fedotov IA, et al. Urol Nefrol (Mosk). 1983 Jan-Feb;(1):63-70. Urol Nefrol (Mosk). 1983. PMID: 6187115 Russian. No abstract available.
• Androgen receptor assays in advanced prostatic cancer.

  Buttyan R, Olsson CA. Buttyan R, et al. Urol Clin North Am. 1984 May;11(2):311-7. Urol Clin North Am. 1984. PMID: 6375068 Review.